Vaginal intraepithelial neoplasia (VaIN) is a precancerous condition that affects the vaginal epithelial cells. It is caused by a human papillomavirus (HPV) infection, and it is the most common precancerous condition in the genital tract of women. The most commonly affected age group is women between the ages of 30 and 50. VaIN is characterized by an abnormal growth of the epithelial cells in the vagina. This abnormal growth can lead to an increased risk of developing cancer, as the abnormal cells are more likely to become cancerous. Symptoms of VaIN can include abnormal vaginal bleeding, itching, and an unusual discharge. Diagnosis of VaIN is typically done through a physical exam and pap smear. A biopsy may be necessary to confirm the diagnosis. Treatment typically involves the use of topical medications, such as antiviral medications or topical retinoids. In some cases, a procedure called laser ablation may be used to remove any abnormal cells. It is important for women to be aware of VaIN as it can lead to an increased risk of developing cancer. Regular pap smears and pelvic exams can help to identify any abnormal cells and early treatment can help to reduce the risk of developing cancer.
Title : Understanding pelvic organ prolapse
Woojin Chong, NYU Langone Medical Center, United States
Title : Vaginal colonization by uropathogenic microorganisms: A key contributor to reproductive failure in mice
Vijay Prabha, Panjab University, India
Title : Application of thread technology in aesthetic and functional gynecology
Marlen Sulamanidze, Total Charm Clinic, Georgia
Title : Role of artificial intelligence in the diagnosis and management of endometriosis. The prospect of the future
Mohamed M Hosni, London North West University Healthcare NHS Trust, United Kingdom
Title : Dr. Mhatre’s laparoscopic peritoneal vaginoplasty (creating normal vagina) – Progenitor cell identification and genetic decoding of MRKH
Pravin Mhatre, G S Medical college KEM, India
Title : Eliminating suffering from breast cancer -The Lavender Way
Phillip Bretz, Visionary Breast Center, United States